National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
In English | En español
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
Clinical Trials (PDQ®)
Patient VersionHealth Professional Version
Page Options
Print This Page  Print This Page
E-Mail This Document  E-Mail This Document
Clinical Trial Questions?
Get Help:

1-800-4-CANCER or

LiveHelp online chat

Quick Links
Help Using the NCI Clinical Trials Search Form

Educational Materials About Clinical Trials

About NCI's Cancer Clinical Trials Registry

Dictionary of Cancer Terms

NCI Drug Dictionary
ZD4054 in Pain-free or Mildly Symptomatic Patients with Prostate Cancer and Bone Metastases who have Rising Serum Prostate Specific Antigen (PSA)

Basic Trial Information
Trial Description
     Summary
     Eligibility Criteria
Trial Contact Information

Basic Trial Information

PhaseTypeStatusAgeSponsorProtocol IDs
Phase IITreatmentActive18 and overPharmaceutical / IndustryD4320C00006
Trial 6, ZD4054, NCT00090363

Trial Description

Summary

Randomized, double-blind, parallel-group, placebo-controlled, multi-centre study to assess ZD4054 in pain-free or mildly symptomatic patient with prostate cancer and bone metastases who have rising serum prostate specific antigen (PSA)

Eligibility Criteria

Inclusion Criteria:

  • Surgically or medically castrated
  • Bone metastasis
  • Rising PSA

Exclusion Criteria:

  • Opiate use
  • Prior chemotherapy

Trial Contact Information

Trial Lead Organizations/Sponsors

AstraZeneca Pharmaceuticals LP

AstraZeneca Information Center (8 AM – 7 PM EST)Ph: 1-800-236-9933

Trial Sites

U.S.A.
Arizona
  Gleason
 Research Site
  Tucson
 Research Site
California
  Los Angeles
 Research Site
Illinois
  Chicago
 Research Site
  Chodak
 Research Site
Maryland
  Baltimore
 Research Site
Ohio
  Cleveland
 Research Site

Link to the current ClinicalTrials.gov record.
NLM Identifer NCT00090363
Information obtained from ClinicalTrials.gov on 2005-02-24

Note: Information about this trial is from the ClinicalTrials.gov database. The versions designated for health professionals and patients contain the same text. Minor changes may be made to the ClinicalTrials.gov record to standardize the names of study sponsors, sites, and contacts. Cancer.gov only lists sites that are recruiting patients for active trials, whereas ClinicalTrials.gov lists all sites for all trials. Questions and comments regarding the presented information should be directed to ClinicalTrials.gov.

Back to TopBack to Top

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov